Recent Ovarian Cancer News

It’s in the Genes: Genetic Testing for Ovarian Cancer  (March 15, 2018)

What your DNA reveals and why it’s worth knowing CancerConnect News: Ovarian cancer is often dubbed as the “silent killer” of women. The symptoms are vague—including bloating, fatigue, irregular... Continue Reading

Chemo Bath Improves Ovarian Cancer Survival (January 22, 2018)

CancerConnect News: A heated chemotherapy bath circulated throughout the abdomen after surgery can significantly prolong a woman’s survival with advanced ovarian cancer, according to the results of a... Continue Reading

Rubraca Significantly Improves Survival Ovarian Cancer (January 18, 2018)

CancerConnect News: According to the results of a recently published clinical trail the novel precision cancer medicine Rubraca® (rucaparib) improves the outcomes of individuals with advanced ovarian... Continue Reading

Ovarian Cancer: Doctors at Sloan Kettering Explore Immunotherapy (January 16, 2018)

CancerConnect News:  All gynecologic cancers are challenging to treat. They can be hard to find and are usually diagnosed when they are advanced. Although these cancers can be held at bay with surgery... Continue Reading

Pass it On: It’s National Ovarian Cancer Awareness Month (September 11, 2017)

In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The incidence of ovarian cancer has decreased slightly... Continue Reading

Ovarian Cancer Clinical Trials: What, Where, Why (July 5, 2017)

Pre-recorded webinar on Thursday, July 13th, 7–8 p.m. EST Have questions about ovarian cancer clinical trials? Join the National Ovarian Cancer Coalition® (NOCC) for an Ask the Expert session with... Continue Reading

Endometriosis Patients are at Increased Risk for Ovarian Cancer, Study Confirms (May 3, 2017)

A large study based on the Nurses’ Health confirms that endometriosis is associated with increased risk of ovarian cancer.  Moreover, it further clarifies that this condition is not linked to a greater... Continue Reading

Recruitment Begins for World’s First Ovarian Cancer Vaccine Trial (April 25, 2017)

UConn Health is beginning to recruit patients for the world’s first personalized genomics-driven ovarian cancer vaccine clinical trial. The goal: to prevent an often deadly relapse of the disease in... Continue Reading

Niraparib Approved for Ovarian Cancer Maintenance Treatment (April 3, 2017)

Zejula (Niraparib) has been approved by the US Food and Drug Administration (FDA) for use as maintenance therapy in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal who... Continue Reading

New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response? (March 6, 2017)

A clinical study with Keytruda (pembrolizumab) in a novel untried combination is the first ovarian cancer clinical trial to incorporate gut flora analysis.  Dr. Emese Zsiros, the study’s Principal... Continue Reading

Next Page »